BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15107462)

  • 1. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors.
    Chen Y; Shukla A; Namiki S; Insel PA; Junger WG
    J Leukoc Biol; 2004 Jul; 76(1):245-53. PubMed ID: 15107462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertonic saline enhances neutrophil elastase release through activation of P2 and A3 receptors.
    Chen Y; Hashiguchi N; Yip L; Junger WG
    Am J Physiol Cell Physiol; 2006 Apr; 290(4):C1051-9. PubMed ID: 16282197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine-stimulated adrenal steroidogenesis involves the adenosine A2A and A2B receptors and the Janus kinase 2-mitogen-activated protein kinase kinase-extracellular signal-regulated kinase signaling pathway.
    Chen YC; Huang SH; Wang SM
    Int J Biochem Cell Biol; 2008; 40(12):2815-25. PubMed ID: 18582595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a novel resuscitation strategy combining pentoxifylline and hypertonic saline on neutrophil MAPK signaling.
    Deree J; Melbostad H; Loomis WH; Putnam JG; Coimbra R
    Surgery; 2007 Aug; 142(2):276-83. PubMed ID: 17689696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of the P2Y14 receptor in human neutrophils.
    Scrivens M; Dickenson JM
    Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors.
    Bouma MG; Jeunhomme TM; Boyle DL; Dentener MA; Voitenok NN; van den Wildenberg FA; Buurman WA
    J Immunol; 1997 Jun; 158(11):5400-8. PubMed ID: 9164961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release.
    Koolpe M; Pearson D; Benton HP
    Arthritis Rheum; 1999 Feb; 42(2):258-67. PubMed ID: 10025919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertonic stress regulates T-cell function by the opposing actions of extracellular adenosine triphosphate and adenosine.
    Yip L; Cheung CW; Corriden R; Chen Y; Insel PA; Junger WG
    Shock; 2007 Mar; 27(3):242-50. PubMed ID: 17304104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: involvement of mechanical stress-activated calcium influx, PKC and Src activation.
    Katz S; Boland R; Santillán G
    Int J Biochem Cell Biol; 2006; 38(12):2082-91. PubMed ID: 16893669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38.
    Junger WG; Hoyt DB; Davis RE; Herdon-Remelius C; Namiki S; Junger H; Loomis W; Altman A
    J Clin Invest; 1998 Jun; 101(12):2768-79. PubMed ID: 9637711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ATP through P2 receptors activates AMP-activated protein kinase and suppresses superoxide generation in cultured mouse podocytes.
    Piwkowska A; Rogacka D; Jankowski M; Angielski S
    Exp Cell Res; 2011 Aug; 317(13):1904-13. PubMed ID: 21550339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor.
    Wen LT; Knowles AF
    Br J Pharmacol; 2003 Nov; 140(6):1009-18. PubMed ID: 14530217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation.
    Loomis WH; Namiki S; Ostrom RS; Insel PA; Junger WG
    J Biol Chem; 2003 Feb; 278(7):4590-6. PubMed ID: 12464620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung.
    Heller AR; Rothermel J; Weigand MA; Plaschke K; Schmeck J; Wendel M; Bardenheuer HJ; Koch T
    Eur J Anaesthesiol; 2007 Mar; 24(3):258-66. PubMed ID: 17094869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of P2 nucleotide receptors stimulates acid efflux from astrocytes.
    Dixon SJ; Yu R; Panupinthu N; Wilson JX
    Glia; 2004 Sep; 47(4):367-76. PubMed ID: 15293234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Neutrophils by Hypertonic Saline Involves Pannexin-1, CD39, CD73, and Other Ectonucleotidases.
    Chen Y; Bao Y; Zhang J; Woehrle T; Sumi Y; Ledderose S; Li X; Ledderose C; Junger WG
    Shock; 2015 Sep; 44(3):221-7. PubMed ID: 26009814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes.
    Bullough DA; Magill MJ; Firestein GS; Mullane KM
    J Immunol; 1995 Sep; 155(5):2579-86. PubMed ID: 7650388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic receptor activation inhibits mitogen-stimulated proliferation in primary neurospheres from the adult mouse subventricular zone.
    Stafford MR; Bartlett PF; Adams DJ
    Mol Cell Neurosci; 2007 Aug; 35(4):535-48. PubMed ID: 17553694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway.
    Pines A; Bivi N; Vascotto C; Romanello M; D'Ambrosio C; Scaloni A; Damante G; Morisi R; Filetti S; Ferretti E; Quadrifoglio F; Tell G
    J Cell Physiol; 2006 Oct; 209(1):44-55. PubMed ID: 16741950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular ATP activates ERK1/ERK2 via a metabotropic P2Y1 receptor in a Ca2+ independent manner in differentiated human skeletal muscle cells.
    May C; Weigl L; Karel A; Hohenegger M
    Biochem Pharmacol; 2006 May; 71(10):1497-509. PubMed ID: 16533496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.